ArticleiScience2026

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway.

Changqing Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.